Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Patterns and functional consequences of antibody speciation in maternal-fetal transfer of coronavirus-specific humoral immunity. Local targets link to admitted publications; unresolved targets remain external evidence.
COVID-19 Mortality Update - United States, 2022
10.15585/mmwr.mm7218a4 · 2023 · External reference
Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality
10.1016/j.cell.2020.10.052 · 2020 · External reference
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
10.1038/s41591-021-01540-1 · 2021 · External reference
Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants
10.1126/science.abj4176 · 2021 · External reference
The effect of spike mutations on SARS-CoV-2 neutralization
10.1016/j.celrep.2021.108890 · 2021 · External reference
Plasma Neutralization of the SARS-CoV-2 Omicron Variant
10.1056/nejmc2119641 · 2022 · External reference
Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses
10.1126/scitranslmed.abn7842 · 2022 · External reference
Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines
10.1038/s41467-022-31929-6 · 2022 · External reference
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
10.1038/s41586-021-03398-2 · 2021 · External reference
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
10.1038/s41586-021-03324-6 · 2021 · External reference
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
10.1016/j.cell.2021.02.037 · 2021 · External reference
Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons
10.1056/nejmoa2104983 · 2021 · External reference
Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion
10.1056/nejmc2113891 · 2021 · External reference
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
10.1056/nejmoa2035389 · 2021 · External reference
An mRNA Vaccine against SARS-CoV-2 - Preliminary Report
10.1056/nejmoa2022483 · 2020 · External reference
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
10.1056/nejmoa2034577 · 2020 · External reference
Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery
10.1097/aog.0000000000004693 · 2022 · External reference
Safety and Effectiveness of Maternal COVID-19 Vaccines Among Pregnant People and Infants
10.1016/j.ogc.2023.02.003 · 2023 · External reference
Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy
10.1038/s41467-022-30052-w · 2022 · External reference
Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States
10.1001/jamanetworkopen.2022.33273 · 2022 · External reference
The impact of maternal SARS-CoV-2 infection and COVID-19 vaccination on maternal-fetal outcomes
10.1016/j.reprotox.2022.10.003 · 2022 · External reference
Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants
10.1056/nejmoa2204399 · 2022 · External reference
Maternal vaccination: a review of current evidence and recommendations
10.1016/j.ajog.2021.10.041 · 2022 · External reference
IgG placental transfer in healthy and pathological pregnancies
10.1155/2012/985646 · 2012 · External reference
The Impact of IgG transplacental transfer on early life immunity
10.4049/immunohorizons.1700057 · 2018 · External reference
Postacute Sequelae of SARS-CoV-2 in Children
2024 · External reference
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
10.1056/nejmoa2021680 · 2020 · External reference
SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland
10.1038/s41591-021-01666-2 · 2022 · External reference
Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study
10.1016/s2213-2600(22)00360-5 · 2022 · External reference
Effects of COVID-19 vaccination during pregnancy on SARS-CoV-2 infection and maternal and neonatal outcomes: A systematic review and meta-analysis
10.1002/rmv.2434 · 2023 · External reference
FcRn, but not FcγRs, drives maternal-fetal transplacental transport of human IgG antibodies
10.1073/pnas.2004325117 · 2020 · External reference
Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies
10.1073/pnas.0606304103 · 2006 · External reference
The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans
10.1093/intimm/13.8.993 · 2001 · External reference
FcRn: the MHC class I-related receptor that is more than an IgG transporter
10.1016/s0167-5699(97)01172-9 · 1997 · External reference
Crystal structure of the complex of rat neonatal Fc receptor with Fc
10.1038/372379a0 · 1994 · External reference
Dynamic changes of acquired maternal SARS-CoV-2 IgG in infants
10.1038/s41598-021-87535-x · 2021 · External reference
Maternal Antibody Response, Neutralizing Potency, and Placental Antibody Transfer After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
10.1097/aog.0000000000004440 · 2021 · External reference
Compromised SARS-CoV-2-specific placental antibody transfer
10.1016/j.cell.2020.12.027 · 2021 · External reference
Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios
10.1001/jamapediatrics.2021.0038 · 2021 · External reference
Maternal and Neonatal SARS-CoV-2 Immunoglobulin G Antibody Levels at Delivery After Receipt of the BNT162b2 Messenger RNA COVID-19 Vaccine During the Second Trimester of Pregnancy
10.1001/jamapediatrics.2021.5683 · 2022 · External reference
Cord blood antibodies following maternal coronavirus disease 2019 vaccination during pregnancy
10.1016/j.ajog.2021.03.035 · 2021 · External reference
Evaluation of SARS-CoV-2 Spike Protein Antibody Titers in Cord Blood after COVID-19 Vaccination during Pregnancy in Polish Healthcare Workers: Preliminary Results
10.3390/vaccines9060675 · 2021 · External reference
Cord blood antibody following maternal SARS-CoV-2 inactive vaccine (CoronaVac) administration during the pregnancy
10.1080/21645515.2021.1947099 · 2021 · External reference
Evidence for the Role of a Second Fc-Binding Receptor in Placental IgG Transfer in Nonhuman Primates
10.1128/mbio.00341-23 · 2023 · External reference
Noncanonical placental Fc receptors: What is their role in modulating transplacental transfer of maternal IgG?
10.1371/journal.ppat.1007161 · 2018 · External reference
Maternal gatekeepers: How maternal antibody Fc characteristics influence passive transfer and infant protection
10.1371/journal.ppat.1008303 · 2020 · External reference
Comparison of Maternal and Neonatal Antibody Levels After COVID-19 Vaccination vs SARS-CoV-2 Infection
10.1001/jamanetworkopen.2022.40993 · 2022 · External reference
Timing of SARS-CoV-2 vaccination during the third trimester of pregnancy and transplacental antibody transfer: a prospective cohort study
10.1016/j.cmi.2021.10.003 · 2022 · External reference
Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine
10.1172/jci150319 · 2021 · External reference
COVID-19 mRNA vaccines drive differential antibody Fc-functional profiles in pregnant, lactating, and nonpregnant women
10.1126/scitranslmed.abi8631 · 2021 · External reference
Diverging Maternal and Cord Antibody Functions From SARS-CoV-2 Infection and Vaccination in Pregnancy
10.1093/infdis/jiad421 · 2023 · External reference
Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms
10.1038/s41467-022-31169-8 · 2022 · External reference
Comprehensive serologic profile and specificity of maternal and neonatal cord blood SARS-CoV-2 antibodies
10.1016/j.xagr.2021.100046 · 2022 · External reference
Antibody response, neutralizing potency, and transplacental antibody transfer following SARS-CoV-2 infection versus mRNA-1273, BNT162b2 COVID-19 vaccination in pregnancy
10.1002/ijgo.14648 · 2023 · External reference
SARS-CoV-2 neutralizing antibody titers in maternal blood, umbilical cord blood, and breast milk
10.1038/s41372-023-01843-w · 2024 · External reference
Passive antibody transfer from pregnant women to their fetus are maximized after SARS-CoV-2 vaccination irrespective of prior infection
10.1016/j.jacig.2023.100189 · 2024 · External reference
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn
10.1016/j.vaccine.2023.06.032 · 2023 · External reference
Maternal and Placental Antibody Responses in SARS-CoV-2 Vaccination and Natural Infection During Pregnancy
10.1097/inf.0000000000004704 · 2025 · External reference
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection
10.7554/elife.73490 · 2022 · External reference
SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses
10.1016/j.ebiom.2023.104893 · 2023 · External reference
SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals
10.1038/s41467-022-32389-8 · 2022 · External reference
The Anti-SARS-CoV-2 IgG1 and IgG3 Antibody Isotypes with Limited Neutralizing Capacity against Omicron Elicited in a Latin Population a Switch toward IgG4 after Multiple Doses with the mRNA Pfizer-BioNTech Vaccine
10.3390/v16020187 · 2024 · External reference
Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination depends on prior infection history
10.1038/s41598-023-40103-x · 2023 · External reference
Dynamics of Different Classes and Subclasses of Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants after Coronavirus Disease 2019 and CoronaVac Vaccination in Thailand
10.1128/msphere.00465-22 · 2023 · External reference
Understanding low COVID-19 booster uptake among US adults
10.1016/j.vaccine.2023.08.080 · 2023 · External reference
Maternal hybrid immunity and risk of infant COVID-19 hospitalizations: national case-control study in Israel
10.1038/s41467-024-46694-x · 2024 · External reference
Maternal third dose of BNT162b2 mRNA vaccine and risk of infant COVID-19 hospitalization
10.1038/s41591-023-02270-2 · 2023 · External reference
Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life
10.1038/s41467-023-36547-4 · 2023 · External reference
Priming conditions shape breadth of neutralizing antibody responses to sarbecoviruses
10.1038/s41467-022-34038-6 · 2022 · External reference
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination
10.1016/j.cell.2022.01.018 · 2022 · External reference
Durability and breadth of neutralisation following multiple antigen exposures to SARS-CoV-2 infection and/or COVID-19 vaccination
10.1016/j.ebiom.2023.104475 · 2023 · External reference
Maternal SARS-CoV-2 infection elicits sexually dimorphic placental immune responses
10.1126/scitranslmed.abi7428 · 2021 · External reference
SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons
10.1056/nejmc2119236 · 2022 · External reference
COVID-19 vaccine induced poor neutralization titers for SARS-CoV-2 omicron variants in maternal and cord blood
10.3389/fimmu.2023.1211558 · 2023 · External reference
Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
10.1016/j.celrep.2020.107725 · 2020 · External reference
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
10.1038/s41577-022-00809-x · 2023 · External reference
Update on Transplacental Transfer of IgG Subclasses: Impact of Maternal and Fetal Factors
10.3389/fimmu.2020.01920 · 2020 · External reference
The half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulin
1988 · External reference
Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases
10.1016/j.molimm.2015.03.255 · 2015 · External reference
Reduced FcRn-mediated transcytosis of IgG2 due to a missing Glycine in its lower hinge
10.1038/s41598-019-40731-2 · 2019 · External reference
Selective transfer of maternal antibodies in preterm and fullterm children
10.1038/s41598-022-18973-4 · 2022 · External reference
Immunomodulation of Antibody Glycosylation through the Placental Transfer
10.3390/ijms242316772 · 2023 · External reference
Fc Glycan-Mediated Regulation of Placental Antibody Transfer
10.1016/j.cell.2019.05.044 · 2019 · External reference
Diverging Maternal and Cord Antibody Functions From SARS-CoV-2 Infection and Vaccination in Pregnancy
10.1093/infdis/jiad421 · 2024 · External reference
Maternal-fetal transport of immunoglobulin G and its subclasses during the third trimester of human pregnancy
10.1111/j.1600-0897.1994.tb00873.x · 1994 · External reference
Placental transport of immunoglobulin G
10.1016/s0264-410x(03)00334-7 · 2003 · External reference
Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy
10.3389/fimmu.2017.01294 · 2017 · External reference
Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike
10.7554/elife.75228 · 2022 · External reference
Antigenic structure of the human coronavirus OC43 spike reveals exposed and occluded neutralizing epitopes
10.1038/s41467-022-30658-0 · 2022 · External reference
Correlates of protection against SARS-CoV-2 infection and COVID-19 disease
10.1111/imr.13091 · 2022 · External reference
Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection
10.3201/eid2902.221422 · 2023 · External reference
A Covid-19 Milestone Attained - A Correlate of Protection for Vaccines
10.1056/nejmp2211314 · 2022 · External reference
COVID-19-neutralizing antibodies predict disease severity and survival
2021 · External reference
Convalescent plasma anti-SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization
10.1172/jci141206 · 2020 · External reference
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions
10.1371/journal.ppat.1011569 · 2024 · External reference
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
10.1016/j.cell.2021.06.021 · 2021 · External reference
Maternal-Fetal Outcomes and Antibody Transfer, Depending on the Trimester of SARS-CoV-2 Infection in Non-Vaccinated Women-A Danish Nationwide Prospective Cohort Study
10.3390/ijms26062533 · 2025 · External reference
Timing of Maternal COVID-19 Vaccine and Antibody Concentrations in Infants Born Preterm
10.1001/jamanetworkopen.2023.52387 · 2024 · External reference
Effects of the timing of maternal SARS-CoV-2 infection and vaccination status on placental transfer of antibodies to neonates: A cross-sectional study
10.1016/j.ijid.2024.107098 · 2024 · External reference
Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection
10.1001/jama.2022.1206 · 2022 · External reference
Phagocytic ability of neutrophils and monocytes in neonates
10.1186/1471-2431-11-29 · 2011 · External reference
Off to a slow start: under-development of the complement system in term newborns is more substantial following premature birth
10.1016/j.imbio.2011.07.027 · 2012 · External reference
Phagocytosis of neonatal pathogens by peripheral blood neutrophils and monocytes from newborn preterm and term infants
10.1038/pr.2013.145 · 2013 · External reference
Advantages and Limitations of the Neonatal Immune System
10.3389/fped.2020.00005 · 2020 · External reference
Alternative pathway activation of the complement system in preterm infants with early onset infection
10.1203/00006450-199703000-00005 · 1997 · External reference
SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations
10.1038/s41467-023-40960-0 · 2023 · External reference
Highly parallel characterization of IgG Fc binding interactions
10.4161/mabs.28808 · 2014 · External reference
High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samples
10.1016/j.jim.2012.09.007 · 2012 · External reference
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
10.1038/s41586-020-2349-y · 2020 · External reference
Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1
10.1126/science.1187659 · 2010 · External reference
Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles
10.1016/j.jim.2017.01.010 · 2017 · External reference
Optimization and qualification of an Fc Array assay for assessments of antibodies against HIV-1/SIV
10.1016/j.jim.2018.01.013 · 2018 · External reference
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant
10.1038/s41541-022-00459-z · 2022 · External reference
A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples
10.1016/j.jim.2010.12.016 · 2011 · External reference
Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals
10.3389/fimmu.2020.618685 · 2021 · External reference
A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation
10.1016/j.jim.2019.07.002 · 2019 · External reference
Decoding human-macaque interspecies differences in Fc-effector functions: The structural basis for CD16-dependent effector function in Rhesus macaques
10.3389/fimmu.2022.960411 · 2022 · External reference
